Showing results (1-10 of 108) with videos related to
Sort By:
Pageof 11
International Journal of Laboratory Hematology|February 13, 2021
The effect of erythrocyte lysing reagents on enumeration of leukocyte subpopulations compared with a no-lyse-no-wash protocolKarin Plank, Carla Dorn, Stefan W KrauseAmerican Journal of Clinical Pathology|April 19, 2013
Comparison of automated differential blood cell counts from Abbott Sapphire, Siemens Advia 120, Beckman Coulter DxH 800, and Sysmex XE-2100 in normal and pathologic samplesLisa Meintker, Jürgen Ringwald, Manfred Rauh, et al.British Journal of Haematology|April 6, 2017
Measurements of immature platelets with haematology analysers are of limited value to separate immune thrombocytopenia from bone marrow failureAnnalina Cybulska, Lisa Meintker, Jürgen Ringwald, et al.British Journal of Haematology|March 12, 2002
Adoptive therapy with monocyte-derived macrophages in the setting of high-dose chemotherapy and peripheral blood stem cell transplantationStefan W Krause, Marcus Gnad, Albrecht Reichle, et al.International Wound Journal|April 24, 2018
Genital ulcers as diagnostic clue for acute myeloid leukaemiaSina D Schröder, Stefan W Krause, Cornelia Erfurt-BergeClinical Chemistry and Laboratory Medicine|June 27, 2013
Measurement of immature platelets with Abbott CD-Sapphire and Sysmex XE-5000 in haematology and oncology patientsLisa Meintker, Maria Haimerl, Jürgen Ringwald, et al.Deutsche Medizinische Wochenschrift (1946)|September 14, 2017
[Priorities of German Oncologists. Results of the "choosing wisely" survey of the German Society of Hematology and Medical Oncology (DGHO)]Stefan W Krause, Michael Oldenburg, Michael Hallek, et al.Methods (San Diego, Calif.)|September 6, 2003
The JAM-assay: optimized conditions to determine death-receptor-mediated apoptosisSabine Hoves, Stefan W Krause, Jürgen Schölmerich, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 8, 2013
Rationing cancer care: a survey among the members of the german society of hematology and oncologyStefan W Krause, Jan Schildmann, Christian Lotze, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 27, 2006
Ex vivo-activated human macrophages kill chronic lymphocytic leukemia cells in the presence of rituximab: mechanism of antibody-dependent cellular cytotoxicity and impact of human serumMarie-Laure Lefebvre, Stefan W Krause, Margarita Salcedo, et al.Pageof 11